Management & Advisors
Company
Alan West, President and CEO has had over 20 years of experience in managing medical device start-up companies with a track record that includes both large and small companies, including Johnson & Johnson, Advanced Mechanical Technologies, Boston Scientific Corporation, Vision Sciences, Inc. and Assurance Medical, Inc. Mr. West was V.P. of R&D at Boston Scientific prior to their successful IPO, has a broad technical and business background, and has developed and marketed products in the radiology, cardiology, vascular surgery, dermatology, neurosurgery, gastroenterology, oncology, general surgery, sports medicine and orthopaedic markets. In his career, he has raised more than $45M through private and public offerings and holds numerous patents. Mr. West received a Bachelor's degree in Engineering from Brown University and a Masters in Design from Tufts University.Phil Campbell, Founder and Chief Scientific Officer is a Research Professor in the Institute for Complex Engineered Systems within CMU's Carnegie Institute of Technology with joint appointments in Biomedical Engineering, Material Science and Engineering, the Molecular Biosensor and Imaging Center, and the Biological Sciences Departments. Dr. Campbell's specialty is endocrinology with his primary focus area in understanding hormone pericellular bioavailability as a basis for developing more effective hormone delivery therapies. He is considered a pioneer in identifying pericellular protolytic mechanisms regulating growth factor bioavailability. His current research areas include applying these concepts to biological patterning using bio-printing techniques to better understand the underlying biological concepts of adult stem cell fate (cell migration, proliferation, differentiation, and cell lineage). Dr. Campbell is also developing various in vitro and in vivo imaging strategies based on fluorescence to non-invasively follow cell fate, tissue engineered scaffold degradation and tissue in-growth. He is also involved in developing new native based bio-polymers for tissue engineering applications. He has extensive experience in cell culture and in various animal models for musculoskeletal repair. (http://www.ices.cmu.edu/phil_campbell.html)
Lee Weiss, Ph.D., Founder and Board Member is a Research Professor in the Robotics Institute of the School of Computer Science at Carnegie Mellon University. He also holds appointments in the Biomedical Engineering and Materials Science and Engineering Departments in the College of Engineering. Dr. Weiss currently conducts interdisciplinary research in bioprinting and printable electronics. Over the last 30 years he also has sought to apply his diverse background to create technology-based solutions to challenging problems in health care delivery, including fetal heart monitoring, cardiac pacing, angioplasty, MEMS-based drug delivery, bone regeneration, and computer-aided surgery. He holds 25 U.S. patents. (http://www.ri.cmu.edu/person.html?person_id=336)
James Burgess, M.D., Founder has an academic appointment at Drexel University and adjunct appointments at George Mason University's Krasnow Institute and Carnegie Mellon University's Robotics Institute. Dr. Burgess is a staff neurosurgeon at Allegheny General Hospital in Pittsburgh, PA. His areas of surgical expertise include degenerative spinal disease, minimally invasive surgical procedures. His areas of research interest include spinal instrumentation, human factors in surgery, brain trauma, brain blood flow analysis, bone tissue engineering and robotic image guided surgical applications. (http://www.wpahs.org/patients/physician/index.cfm?mode=Bio&physician=178)
Paul Kornblith, M.D., Chairman An entrepreneur, neurosurgeon, academic, and inventor, he founded Precision Therapeutics Inc. of Pittsburgh, which has raised $120 million in venture capital, and also serves as Western Pennsylvania representative of the Pennsylvania Biotechnology Association, as a consultant to the Pittsburgh Life Sciences Greenhouse, and as a member or chairman of the boards of several companies.
Scientific Advisors
Gail K. Naughton, Ph.D. is the Dean of the College of Business Administration at San Diego State University. Previously, Gail co-founded Advanced Tissue Sciences, which raised over $350M from public and corporate sources. She holds over 90 U.S. and foreign patents and has extensive experience in tissue engineering. She serves on a number of boards, including DermTech International, C.R. Bard and SYS Technologies, Inc.Darrell J. Triulzi, M.D. is the Director, Division of Transfusion Medicine, Department of Pathology at the University of Pittsburgh; and Medical Director of the Institute for Transfusion Medicine (ITXM). Dr. Triulzi's interest is in transfusion support of stem cell and solid organ transplant recipients and the immunomodulatory effects of transfusion. He is site PI for the NIH Transfusion Medicine/Hemostasis Clinical Trials Network. (http://path.upmc.edu/personnel/faculty/triulzi.htm)